News and Insights

Malaria Briefing 2024

April 11, 2024

Malaria is a life-threatening parasitic disease transmitted through the bites of infected female Anopheles mosquitoes. The World Health Organization (WHO) defines malaria as “a preventable and treatable disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes” (WHO, 2021). The disease is caused by Plasmodium parasites, with P. falciparum being the deadliest species, accounting for the majority of malaria cases and deaths globally (WHO, 2021). Additionally, the Anopheles stephensi mosquito is a major vector of malaria in south Asia, the Middle East, and southern China, where it is endemic and is known to transmit both Plasmodium falciparum and P. vivax.

Despite being preventable and treatable, malaria continues to have a significant global impact, particularly in sub-Saharan Africa and parts of Asia. In 2022, the WHO estimated that there were 249 million malaria cases worldwide, resulting in an estimated 608,000 deaths (WHO, 2022). The African region continues to bear the heaviest burden, accounting for 95% of all malaria cases and 96% of all malaria deaths in 2020 (WHO, 2021).

The impact of malaria extends beyond the direct health consequences, affecting the social and economic well-being of individuals, families, and communities. As stated by the WHO, “Malaria is a major cause of poverty and slows economic growth by up to 1.3% per year in endemic countries” (WHO, 2021). The disease disproportionately affects poor and marginalised populations, perpetuating a cycle of poverty and ill health.

The Global Health Impact group understands the complex landscape of malaria and the critical role that various stakeholders play in the fight against this deadly disease. By leveraging expertise in advocacy, communications, and partnerships, Global Health Impact can contribute to the global effort to control and eliminate malaria, ultimately saving lives and improving the health and well-being of communities worldwide.

VIEW WHITE PAPER HERE

Cover of 'Malaria Briefing 2024' by FINN Partners